Showing results (221-230 of 400) with videos related to
Sort By:
Pageof 40
Frontiers in Immunology|October 7, 2021
Efficacy of Immune Checkpoint Inhibitors in Rare Tumours: A Systematic ReviewFausto Petrelli, Francesca Consoli, Antonio Ghidini, et al.Tumori|June 6, 2025
Adding immune checkpoint inhibitors to chemotherapy in elderly cancer patients: Beneficial for many but not all?Fausto Petrelli, Antonio Ghidini, Italo Sarno, et al.Oncology|November 6, 2002
Postoperative hyperprolactinemia could predict longer disease-free and overall survival in node-negative breast cancer patientsMario Mandalà, Paolo Lissoni, Gianluigi Ferretti, et al.The Lancet. Oncology|May 17, 2014
Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarker-stratified, randomised phase 3 trialVanesa Gregorc, Silvia Novello, Chiara Lazzari, et al.Critical Reviews in Oncology/Hematology|October 17, 2022
Different neoadjuvant therapies for locally advanced rectal cancer: A systematic review and network meta-analysisFausto Petrelli, Francesca Trevisan, Gianluca Tomasello, et al.Tumori|January 31, 2025
Adjuvant chemotherapy in elderly patients with HER2-negative early breast cancer: A systematic review and meta-analysisFausto Petrelli, Lorenzo Dottorini, Italo Sarno, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 12, 2020
Pharmacological issues concerning olaparib capsule and tablet formulations in treating ovarian cancer: Are they really the same drug?Gianluca Perego, Renata Nozza, Emanuela Oggionni, et al.Critical Reviews in Oncology/Hematology|March 7, 2026
Viral Hepatitis and Immunotherapy Outcome in Advanced Hepatocellular Carcinoma: A Comprehensive Umbrella Review of 15 Meta-AnalysesFausto Petrelli, Silvia Colombo, Lorenzo Dottorini, et al.Journal of Geriatric Oncology|December 11, 2025
Safety of CDK4/6 inhibitors in older patients: A FAERS-based analysis of serious and fatal adverse eventsFausto Petrelli, Alessandro Iaculli, Maria Chiara Parati, et al.Critical Reviews in Oncology/Hematology|February 5, 2021
Outcome of patients with advanced upper tract urothelial carcinoma treated with immune checkpoint inhibitors: A systematic review and meta-analysisMelissa Bersanelli, Sebastiano Buti, Patrizia Giannatempo, et al.Pageof 40